InsidersTradesSigma
큐리언트 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 큐리언트 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 큐리언트 has recorded 8 reports. Market capitalisation: €749bn. The latest transaction was reported on 23 June 2026 (Other). Among the most active insiders: 유암코키스톤구조혁신기업재무안정사모투자. All data is accessible without an account.
8
Insider Decl.
0
Thresholds
€200,698
5 ops.
Buy Volume
·
0 ops.
Sell Volume
31Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,317 of 25,619 companies
15.9
score / 100
Value23
Quality9
FCF yld-4.7%
Earn yld-4.3%
EV/EBITDA·
ROE-75%
Gross mgn13%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 23 June 2026
Declarations8 total
8 of 8 declarations
About 큐리언트
큐리언트 is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative treatments for various diseases.